SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-005595
Filing Date
2022-04-12
Accepted
2022-04-12 08:30:37
Documents
5
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A phat-def_14a-2022_proxy.htm DEF 14A 839466
2 GRAPHIC img33513176_0.jpg GRAPHIC 9568
3 GRAPHIC img33513176_1.jpg GRAPHIC 9568
4 GRAPHIC img33513176_2.jpg GRAPHIC 150550
5 GRAPHIC img33513176_3.jpg GRAPHIC 209923
  Complete submission text file 0000950170-22-005595.txt   1363266
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39094 | Film No.: 22821151
SIC: 2834 Pharmaceutical Preparations